One of the 4 inventors of PBT2 in reversing antibiotic resistance, Dr. Christopher McDevitt has 2 research projects in Melbourne University together with Dr. Stephanie Neville and Dr. Aimee Tan, both under title "Breaking bacterial antibiotic resistance to frontline therapeutics". The team has funding for 2022-2024 for both of these studiesDr Neville has a third study listed only on her name: "Breaking antibiotic resistance in otopathogens". 1 year ago she announced that she will start this otitis study and she has funding for that study for 2022-2023. This was announced widely in the news some 1 year ago and it was told that the main focus would be how PBT2 will possibly help to break the antibiotic resistance common when treating otitis media patients. This was posted also on this board.It is very evident that all these projects are dealing with PBT2 and the first results will be published this year by Dr, Neville about her otitis project. Very likely the 2 other projects will result perhaps several papers in many other clinical infections where breaking of antibiotic resistance is needed.https://findanexpert.unimelb.edu.au/profile/828536-stephanie-neville
ATH Price at posting:
1.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)